GHRP 6 5mg Front
GHRP 6 5mg Back

Buy GHRP-6 5mg Online

GHRP-6 is a synthetic peptide studied for its role in growth hormone release and appetite-related signaling. Research suggests that it may influence endocrine and metabolic regulation, primarily through stimulation of ghrelin receptors involved in hormone secretion and feeding behavior.

$44.00

Contact Us
General info
Brand

NOVERA COMPOUNDS
Strength

5mg
CAS

87616-84-0
Chemical Formula

C₄₆H₅₆N₁₂O₆
Molecular weight

873.03 g/mol
Peptide Sequence

His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Synonyms

GHRP6, Growth Hormone Releasing Peptide-6
Storage

Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
Shelf life

24 months from the manufacturing date.

GHRP-6 (5mg) About This Product 

GHRP-6 (5mg) is a synthetic growth hormone–releasing hexapeptide used in endocrine, neuroendocrine, and metabolic research. The GHRP-6 peptide has a molecular weight of ~840 Da and incorporates L- and D-amino acid residues, which can affect proteolytic susceptibility and receptor-interaction profiles in experimental settings.

GHRP-6 has been examined as a synthetic agonist of the growth hormone secretagogue receptor-1a (GHS-R1a), also called the ghrelin receptor. Receptor activation initiates Gq/phospholipase C (PLC) signaling and calcium-dependent intracellular cascades relevant to growth hormone release and related neuroendocrine signaling under controlled research conditions.

This product is supplied as a sterile, lyophilized powder with ≥98% purity in a sealed research vial. Laboratories that buy GHRP-6 peptide commonly use the 5 mg format for non-clinical study designs.

GHRP-6 (5mg)  Key Features and Benefits 

  • GHS-R1a (Ghrelin Receptor) Agonist: Supports receptor pharmacology and signaling assays
  • D-Amino Acid Composition: Associated with improved experimental stability
  • Low Molecular Weight (~840 Da): Practical for controlled handling
  • Lyophilized Powder: Supports stability and flexible preparation
  • Purity ≥98%: Suitable for research and analytical workflows
  • Sealed, Labeled Vial: Supports traceability and documentation

GHRP-6 (5mg)  Mechanism & Research Applications 

GHRP-6 acts at GHS-R1a, a GPCR expressed in the pituitary, hypothalamus, central nervous system, and select peripheral tissues. Activation triggers Gq/PLC-dependent signaling, leading to inositol triphosphate (IP₃) generation, intracellular calcium mobilization, and kinase activation. These cascades are used to study growth hormone secretion dynamics, metabolic sensing, and gene-expression programs linked to cellular stress, inflammatory signaling, and apoptosis-associated pathways.

In research contexts, GHRP-6 is used to probe GHS-R1a activation kinetics, tissue-specific receptor expression, and downstream signal-transduction networks.

Primary Research Domains

  1. Receptor Pharmacology: Ligand-response profiling, second-messenger readouts, structure–activity work
  2. Neuroscience: Learning/memory endpoints, synaptic plasticity, dopaminergic involvement
  3. Ischemia & Cellular Stress: Apoptosis markers and neuroinflammatory signaling
  4. Extracellular Matrix & Tissue Remodeling: Matrix signatures, migration, wound-model profiling
  5. Cardiac Stress Models: Oxidative injury and necrosis-related endpoints
  6. Motivation & Reward Circuitry: Region-specific behavioral outputs

Preclinical Research Summary

  • Neural Plasticity & Memory: Extinction learning, amygdala-associated LTD, memory encoding
  • Ischemic Brain Injury: Apoptosis-associated markers and neuroinflammation readouts
  • Dopaminergic Mapping: GHS-R expression in substantia nigra linked to motor phenotypes
  • ECM Remodeling: Collagen deposition and proteome-level repair signatures
  • Myocardial Injury/Oxidative Stress: Oxidative injury indices and necrosis markers
  • Motivation & Reward-Seeking: CNS region–dependent effects on motivated behavior

GHRP-6 (5mg) Dosing & Observed Effects in Research

Published studies report microgram-to-milligram use depending on model and design, including cell-based assays, tissue explants, rodent studies, and large-animal preclinical models.

Observed endpoints reported in research settings include:

  • Growth hormone elevation
  • Learning/memory-related behavioral changes
  • Apoptosis and necrosis signaling markers
  • Inflammatory cytokine pathway modulation
  • Oxidative-stress and antioxidant-response markers
  • Extracellular-matrix expression and collagen deposition
  • Reward-seeking and motivated-behavior outputs
  • Dopaminergic neuron response modulation

All findings remain preclinical and model-specific.

GHRP-6 (5mg)  Storage, Safety & References

Store lyophilized material protected from light and moisture:

  • Short-term: 2–8°C (days to weeks)
  • Long-term: −20°C or lower (−80°C preferred). Avoid repeated freeze–thaw cycles.

Reconstitute using sterile laboratory-grade diluent under aseptic technique. Handle with standard PPE and dispose of per institutional requirements. Laboratories that order GHRP-6 peptide are responsible for compliance.

References

https://pubmed.ncbi.nlm.nih.gov/8903947

https://pmc.ncbi.nlm.nih.gov/articles/PMC40592

https://pubmed.ncbi.nlm.nih.gov/9543138

https://www.pnas.org/doi/10.1073/pnas.1313798111

https://pubmed.ncbi.nlm.nih.gov/16989643

https://onlinelibrary.wiley.com/doi/10.1155/2016/4361702

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.